David Mushatt is an Infectious Disease physician affiliated with Tulane University. OpenAlex indexes 58 publications with 1,271 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
56.7%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor14.2%Descovy82%Abacavir10%Abacavir-Lamivudine8%Part D<11 patientsProtease Inhibitor11.1%Prezista46%Ritonavir46%Symtuza9%Part D<11 patients+ 15 more classes in this area
Cardiovascular
19%Statin5.6%Pravastatin Sodium31%Atorvastatin Calcium29%Simvastatin24%Rosuvastatin Calcium16%Part D<11 patientsThiazide diuretic4.8%Hydrochlorothiazide100%Part D<11 patients+ 4 more classes in this area
Nervous system
14.5%Benzodiazepine3.1%Lorazepam64%Alprazolam36%Part D<11 patientsSSRI2.3%Escitalopram Oxalate59%Trazodone Hcl41%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1997–2006 per NIH RePORTER. The latest:
- LOUISIANA COMMUNITY AIDS RESEARCH PROGRAM (CPCRA)
Tulane University of Louisiana
FY2006$362,840U01AI042178 - LOUISIANA COMMUNITY AIDS RESEARCH PROGRAM (CPCRA)
Tulane University of Louisiana
FY2005$703,859U01AI042178 - LOUISIANA COMMUNITY AIDS RESEARCH PROGRAM (CPCRA)
Tulane University of Louisiana
FY2004$878,859U01AI042178
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration
Clinical Infectious Diseases
2024 - Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Open Forum Infectious Diseases
2024 - Advancing Health Equity: The Role of a Community–Academic–Public Health–Practice (CAPP) Partnership in Addressing COVID-19 Disparities in Louisiana
American Journal of Public Health
2023
Similar KOLs
Other experts from the same institution or the same specialty.
John Schieffelin, MD
Tulane University
Thierry Lejemtel, MD
Tulane University
Robert Hendel, MD
Tulane University
Vecihi Batuman, MD
Tulane University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”